Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Combe

Showing results (201-210 of 282) with videos related to

Pageof 29
Sort By:
RMD Open|December 10, 2016
Improving inflammatory arthritis management through tighter monitoring of patients and the use of innovative electronic toolsPiet van Riel, Rieke Alten, Bernard Combe, et al.
Arthritis Care & Research|February 13, 2013
Potential classification criteria for rheumatoid arthritis after two years: results from a French multicenter cohortAlain Saraux, Gabriel J Tobón, Mathilde Benhamou, et al.
Joint Bone Spine|December 30, 2006
Clinical practice format for choosing a second-line disease modifying anti-rheumatic drug in early rheumatoid arthritis after failure of 6 months' first-line DMARD therapyOlivier Meyer, Michel de Bandt, Jean-Marie Berthelot, et al.
Joint Bone Spine|October 14, 2018
Update of French society for rheumatology recommendations for managing rheumatoid arthritisClaire Daien, Charlotte Hua, Cécile Gaujoux-Viala, et al.
Joint Bone Spine|December 17, 2017
An e-health interactive self-assessment website (Sanoia<sup>®</sup>) in rheumatoid arthritis. A 12-month randomized controlled trial in 320 patientsLaure Gossec, Alain Cantagrel, Martin Soubrier, et al.
Annals of the Rheumatic Diseases|November 2, 2016
Patient-reported outcomes from a randomised phase III study of baricitinib in patients with rheumatoid arthritis and an inadequate response to biological agents (RA-BEACON)Josef S Smolen, Joel M Kremer, Carol L Gaich, et al.
The Journal of Rheumatology|August 17, 2012
Rituximab treatment for spondyloarthritis. A nationwide series: data from the AIR registry of the French Society of RheumatologyDaniel Wendling, Maxime Dougados, Francis Berenbaum, et al.
Joint Bone Spine|May 29, 2025
Early peripheral psoriatic arthritis: Baseline features of the first 186 patients in the French Nationwide APACHE CohortPascal Claudepierre, Cecile Gaujoux-Viala, Arnaud Constantin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 1, 2021
Safety and Efficacy of Upadacitinib in Patients With Active Ankylosing Spondylitis and an Inadequate Response to Nonsteroidal Antiinflammatory Drug Therapy: One-Year Results of a Double-Blind, Placebo-Controlled Study and Open-Label ExtensionAtul Deodhar, Désirée van der Heijde, Joachim Sieper, et al.
Joint Bone Spine|June 26, 2007
Pharmacotherapy (excluding biotherapies) for ankylosing spondylitis: development of recommendations for clinical practice based on published evidence and expert opinionFrédéric Lavie, Stephan Pavy, Emmanuelle Dernis, et al.
Pageof 29

Showing results (201-210 of 282) with videos related to

Sort By:
Pageof 29
RMD Open|December 10, 2016
Improving inflammatory arthritis management through tighter monitoring of patients and the use of innovative electronic toolsPiet van Riel, Rieke Alten, Bernard Combe, et al.
Arthritis Care & Research|February 13, 2013
Potential classification criteria for rheumatoid arthritis after two years: results from a French multicenter cohortAlain Saraux, Gabriel J Tobón, Mathilde Benhamou, et al.
Joint Bone Spine|December 30, 2006
Clinical practice format for choosing a second-line disease modifying anti-rheumatic drug in early rheumatoid arthritis after failure of 6 months' first-line DMARD therapyOlivier Meyer, Michel de Bandt, Jean-Marie Berthelot, et al.
Joint Bone Spine|October 14, 2018
Update of French society for rheumatology recommendations for managing rheumatoid arthritisClaire Daien, Charlotte Hua, Cécile Gaujoux-Viala, et al.
Joint Bone Spine|December 17, 2017
An e-health interactive self-assessment website (Sanoia<sup>®</sup>) in rheumatoid arthritis. A 12-month randomized controlled trial in 320 patientsLaure Gossec, Alain Cantagrel, Martin Soubrier, et al.
Annals of the Rheumatic Diseases|November 2, 2016
Patient-reported outcomes from a randomised phase III study of baricitinib in patients with rheumatoid arthritis and an inadequate response to biological agents (RA-BEACON)Josef S Smolen, Joel M Kremer, Carol L Gaich, et al.
The Journal of Rheumatology|August 17, 2012
Rituximab treatment for spondyloarthritis. A nationwide series: data from the AIR registry of the French Society of RheumatologyDaniel Wendling, Maxime Dougados, Francis Berenbaum, et al.
Joint Bone Spine|May 29, 2025
Early peripheral psoriatic arthritis: Baseline features of the first 186 patients in the French Nationwide APACHE CohortPascal Claudepierre, Cecile Gaujoux-Viala, Arnaud Constantin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 1, 2021
Safety and Efficacy of Upadacitinib in Patients With Active Ankylosing Spondylitis and an Inadequate Response to Nonsteroidal Antiinflammatory Drug Therapy: One-Year Results of a Double-Blind, Placebo-Controlled Study and Open-Label ExtensionAtul Deodhar, Désirée van der Heijde, Joachim Sieper, et al.
Joint Bone Spine|June 26, 2007
Pharmacotherapy (excluding biotherapies) for ankylosing spondylitis: development of recommendations for clinical practice based on published evidence and expert opinionFrédéric Lavie, Stephan Pavy, Emmanuelle Dernis, et al.
Pageof 29